October 16, 2008
CSL Biotherapies Launches Www.Mercuryfreefluvaccine.Com, An Online, Order-As-You-Go Service for Thimerosal-Free Influenza Vaccine
CSL Biotherapies, a subsidiary of one of the world's leading manufacturers of influenza vaccine, today announced an innovative online quick-ship ordering system, enabling healthcare providers and other purchasers to buy CSL Biotherapies' thimerosal-free flu vaccine for adults directly from the company. This new purchasing platform (accessible at www.mercuryfreefluvaccine.com) offers customers enhanced access to a thimerosal-free product in the quantity they need, whenever they need it.
System features include guaranteed delivery of CSL Biotherapies' thimerosal-free flu vaccine within one to two business days, free shipping (on orders placed Monday through Thursday), and the freedom to place as many orders as necessary throughout the flu season - allowing access to smaller quantities, which will help minimize inventory management issues at the provider office.
CSL is on track to deliver more than six million doses of influenza vaccine for adults during the 2008-2009 season, the majority of which is in thimerosal-free single-dose, pre-filled syringes. This marks a three-fold increase of CSL's vaccine supply to the United States over last season.
Orders placed via the www.mercuryfreefluvaccine.com Web site will ship directly from ASD Healthcare, a business unit of AmerisourceBergen Corp., one of the world's largest pharmaceutical services companies. Customers have the option of completing an online order form or downloading a PDF for faxing. ASD Healthcare has set-up a Web site and fax number for ordering 24-hours, seven days a week.
"ASD Healthcare has distributed flu vaccine for more than a decade, and this year we're seeing a significant increase in demand for thimerosal-free vaccine," said Neil Herson, president of ASD Healthcare. "To meet this customer demand, we're pleased to work with CSL Biotherapies to ensure that thimerosal-free flu vaccine remains an option for providers throughout the season."
About CSL Biotherapies
The U.S. headquarters of CSL Biotherapies are located in King of Prussia, PA. Its parent company, CSL Limited, in Melbourne, Australia, operates one of the world's largest influenza vaccine facilities for global markets. CSL Biotherapies, which shares its U.S. headquarters with its sister company, CSL Behring, is commercializing influenza vaccine products globally. At CSL Biotherapies, delivering vaccines is our mission, protecting lives our passion. The CSL Group, which also includes CSL Research & Development, CSL Bioplasma, and CSL Behring, has more than 8,500 employees and operates in 21 countries worldwide. For more information, visit us at http://www.cslbiotherapies-us.com, or call 1-888-435-8633.
About ASD Healthcare
ASD Healthcare, a business unit of AmerisourceBergen Specialty Group, is a leading provider of IVIG, blood plasma products, influenza vaccine, oncolytics and other specialty pharmaceutical products critical to patient care. More than 3,800 health-system pharmacies and alternate-site practitioners throughout the country rely on ASD Healthcare for guaranteed product integrity and around-the-clock service. For more information, please visit www.asdhealthcare.com or call 800-746-6273.
AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With more than $70 billion in annualized revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 11,200 people. AmerisourceBergen is ranked number 28 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.